These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39113067)

  • 1. Effect of rosuvastatin versus atorvastatin on new-onset diabetes mellitus in patients treated with high-intensity statin therapy for coronary artery disease: a post-hoc analysis from the LODESTAR randomized clinical trial.
    Hong SJ; Lee YJ; Kang WC; Hong BK; Lee JY; Lee JB; Yang TH; Yoon J; Lee SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK;
    Cardiovasc Diabetol; 2024 Aug; 23(1):287. PubMed ID: 39113067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.
    Kang J; Kim YC; Park JJ; Kim S; Kang SH; Cho YJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Chae IH; Choi DJ
    Cardiovasc Diabetol; 2018 Jan; 17(1):10. PubMed ID: 29325562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Pitavastatin Compared with Atorvastatin andRosuvastatin on New-Onset Diabetes Mellitus in PatientsWith Acute Myocardial Infarction.
    Choi JY; Choi CU; Hwang SY; Choi BG; Jang WY; Kim DY; Kim W; Park EJ; Lee S; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Chae SC; Kim YJ; Cho MC; Kim CJ; Kim HS; Jeong MH;
    Am J Cardiol; 2018 Sep; 122(6):922-928. PubMed ID: 30217375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
    Hong SJ; Lee YJ; Lee SJ; Hong BK; Kang WC; Lee JY; Lee JB; Yang TH; Yoon J; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK;
    JAMA; 2023 Apr; 329(13):1078-1087. PubMed ID: 36877807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    Lee YJ; Hong SJ; Kang WC; Hong BK; Lee JY; Lee JB; Cho HJ; Yoon J; Lee SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK;
    BMJ; 2023 Oct; 383():e075837. PubMed ID: 37852649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different diabetogenic effect of statins according to intensity and dose in patients with acute myocardial infarction: a nationwide cohort study.
    Lee J; Choi JY; Choi BG; Choi YJ; Park S; Kang DO; Park EJ; Kim JB; Roh SY; Na JO; Choi CU; Kim EJ; Park CG; Jeong MH; Hwang JY; Hur SH; Jeong JO; Oh S; Rha SW;
    Sci Rep; 2024 Aug; 14(1):19438. PubMed ID: 39169014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases.
    Seo WW; Seo SI; Kim Y; Yoo JJ; Shin WG; Kim J; You SC; Park RW; Park YM; Kim KJ; Rhee SY; Park M; Jin ES; Kim SE
    Cardiovasc Diabetol; 2022 May; 21(1):82. PubMed ID: 35606846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins.
    Choi JY; Choi CU; Choi BG; Park Y; Kang DO; Jang WY; Kim W; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Jeong MH; Chae SC; Seong IW; Yoon CH; Cha KS; Oh SK;
    BMC Pharmacol Toxicol; 2021 Feb; 22(1):11. PubMed ID: 33541430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treat-to-target or high-intensity statin treatment in older adults with coronary artery disease: a post hoc analysis of the LODESTAR trial.
    Lee SJ; Lee JB; Yang TH; Kang WC; Lee JY; Lee YJ; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Hong BK; Choi D; Yoon J; Jang Y; Hong MK;
    Age Ageing; 2024 Jul; 53(7):. PubMed ID: 38965031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
    Foody JM; Toth PP; Tomassini JE; Sajjan S; Ramey DR; Neff D; Tershakovec AM; Hu H; Tunceli K
    Vasc Health Risk Manag; 2013; 9():719-27. PubMed ID: 24265554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
    Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Trends, Effectiveness, and Safety of Statins on Lipid Goal Attainment in Chinese Percutaneous Coronary Intervention Patients: a Multicenter, Retrospective Cohort Study.
    Chen Y; Li D; Jing J; Yan H; Liu J; Shen Z; James S; Varenhorst C
    Clin Ther; 2017 Sep; 39(9):1827-1839.e1. PubMed ID: 28807393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Intensity Versus Non-High-Intensity Statins in Patients Achieving Low-Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention.
    Kim J; Park KT; Jang MJ; Park TK; Lee JM; Yang JH; Song YB; Choi SH; Gwon HC; Lee SH; Hong KP; Hahn JY
    J Am Heart Assoc; 2018 Nov; 7(21):e009517. PubMed ID: 30376751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
    Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
    Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study).
    Ong KL; Waters DD; Messig M; DeMicco DA; Rye KA; Barter PJ
    Am J Cardiol; 2014 May; 113(10):1593-8. PubMed ID: 24666618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D
    Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of high-dose atorvastatin versus rosuvastatin on lipid parameters, oxidized low-density lipoprotein, and proprotein convertase subtilisin kexin 9 in acute coronary syndrome.
    Altunkeser BB; Tuncez A; Ozturk B; Tezcan H; Ates MS; Yilmaz C; Yalcin MU; Aygul N; Demir K
    Coron Artery Dis; 2019 Jun; 30(4):285-290. PubMed ID: 30741744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of High-Intensity Statins in the Veteran Population: Atorvastatin 40 to 80 mg Compared With Rosuvastatin 20 to 40 mg.
    Stein B; Ward T; Hale G; Lyver E
    Ann Pharmacother; 2020 May; 54(5):405-413. PubMed ID: 31718234
    [No Abstract]   [Full Text] [Related]  

  • 19. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of two intensive statin regimens on progression of coronary disease.
    Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE
    N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.